Home Cart 0 Sign in  
X

[ CAS No. 79002-39-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 79002-39-4
Chemical Structure| 79002-39-4
Chemical Structure| 79002-39-4
Structure of 79002-39-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 79002-39-4 ]

Related Doc. of [ 79002-39-4 ]

Alternatived Products of [ 79002-39-4 ]

Product Details of [ 79002-39-4 ]

CAS No. :79002-39-4 MDL No. :MFCD05664402
Formula : C9H5NO Boiling Point : -
Linear Structure Formula :- InChI Key :SXFQAFFSEZRQCJ-UHFFFAOYSA-N
M.W : 143.14 Pubchem ID :2795184
Synonyms :

Calculated chemistry of [ 79002-39-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.93
TPSA : 36.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.86
Log Po/w (XLOGP3) : 2.04
Log Po/w (WLOGP) : 2.3
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 2.38
Consensus Log Po/w : 1.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.62
Solubility : 0.345 mg/ml ; 0.00241 mol/l
Class : Soluble
Log S (Ali) : -2.44
Solubility : 0.515 mg/ml ; 0.0036 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.35
Solubility : 0.0642 mg/ml ; 0.000449 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.32

Safety of [ 79002-39-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 79002-39-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 79002-39-4 ]
  • Downstream synthetic route of [ 79002-39-4 ]

[ 79002-39-4 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 79002-39-4 ]
  • [ 10035-16-2 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: With diisobutylaluminium hydride In n-heptane; dichloromethane at -20 - -15℃; for 0.166667 h;
Stage #2: With hydrogenchloride; water In n-heptane; dichloromethane
EXAMPLE 20
Preparation of 1-benzofuran-5-carbaldehyde
To a solution of 1-benzofuran-5-carbonitrile (5.0 g, 34.9 mmol) in CH2Cl2 under nitrogen at -15 to -20° C. was added DIBAL-H (41.9 mL, 41.9 mmol, 1 M/heptane) and the temperature was maintained below -15° C.
After addition was complete, the reaction mixture was stirred at -15 to -20° C. for an additional 10 min.
The reaction mixture was quenched via dropwise addition of aqueous 2N HCl.
The organic layer was separated and washed with water, dried over sodium sulfate, and concentrated to give 4.0 g (78percent) of 1-benzofuran-5-carbaldehyde as a yellow oil.
78%
Stage #1: With diisobutylaluminium hydride In n-heptane; dichloromethane at -20 - -15℃; for 0.166667 h;
Stage #2: With hydrogenchloride; water In n-heptane; dichloromethane at 20℃;
EXAMPLE 15:PREPARATION OF 5-(5-FORMYL-I -BENZOFURAN-2-YL)-6-METHYL-4-[(4- METHYL-1 H-INDOL-5-YL)AMINO]NICOTINONITRILEStep a): Preparation of 5-formylbenzofuran.To a -150C to -2O0C solution of 1-benzofuran-5-carbonitrile (5 g, 34.9 mmol) in 50 mL of dichloromethane under nitrogen was added DIBAL-H (41.9 mL, 41.9 mmol, 1.0M in heptane) such that the temperature was less than or equal to -150C. The reaction mixture was stirred for an additional 10 min at -150C to -2O0C and quenched by adding 2.0 N HCI dropwise such that the temperature was less than or equal to room temperature. The organic layer was then separated, washed with water, dried over sodium sulfate and concentrated to give 4 g (78percent) of the title compound as a yellow oil, which was used in the next step without further purification.
Reference: [1] Patent: US2007/287738, 2007, A1, . Location in patent: Page/Page column 25
[2] Patent: WO2009/76571, 2009, A1, . Location in patent: Page/Page column 41
[3] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 19, p. 5799 - 5802
  • 2
  • [ 23145-07-5 ]
  • [ 79002-39-4 ]
YieldReaction ConditionsOperation in experiment
85% for 12 h; Inert atmosphere; Reflux General procedure: A mixture of 15, 9k or 9m (190 mmol) and CuCN (49.00 g, 570 mmol) in DMF (500 mL) werestirred at 130 °C (for 15 and 9m) or reflux (for 9k) in N2 atmosphere for 12 h, when TLC analysisindicated completion of reaction. On cooling to room temperature, the reaction mixture was dilutedwith CH2Cl2 (1000 mL), and the resulting mixture was further stirred for 1 h and filtered off. Thefiltrate was washed with 5percent brine (500 mL × 5), dried (Na2SO4) and evaporated on a rotaryevaporator, which was purified by column chromatography to afford 16, 10k or 10m.
Reference: [1] Molecules, 2018, vol. 23, # 2,
[2] Patent: US4341792, 1982, A,
[3] Patent: WO2015/89842, 2015, A1, . Location in patent: Page/Page column 92
[4] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 1, p. 75 - 83
  • 3
  • [ 23145-07-5 ]
  • [ 79002-39-4 ]
Reference: [1] Patent: WO2015/95261, 2015, A1, . Location in patent: Page/Page column 93
  • 4
  • [ 23145-07-5 ]
  • [ 79002-39-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 9, p. 2541 - 2545
  • 5
  • [ 23145-07-5 ]
  • [ 544-92-3 ]
  • [ 79002-39-4 ]
Reference: [1] Journal of Materials Chemistry, 2001, vol. 11, # 11, p. 2759 - 2772
  • 6
  • [ 129969-69-3 ]
  • [ 79002-39-4 ]
Reference: [1] Journal of Materials Chemistry, 2001, vol. 11, # 11, p. 2759 - 2772
  • 7
  • [ 79002-39-4 ]
  • [ 331833-83-1 ]
Reference: [1] Journal of Materials Chemistry, 2001, vol. 11, # 11, p. 2759 - 2772
[2] Patent: WO2010/130796, 2010, A1, . Location in patent: Page/Page column 120
  • 8
  • [ 121-43-7 ]
  • [ 79002-39-4 ]
  • [ 331833-83-1 ]
Reference: [1] Patent: WO2011/61168, 2011, A1, . Location in patent: Page/Page column 54
  • 9
  • [ 5419-55-6 ]
  • [ 79002-39-4 ]
  • [ 331833-83-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 1, p. 75 - 83
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 79002-39-4 ]

Nitriles

Chemical Structure| 6476-32-0

[ 6476-32-0 ]

2-Phenoxybenzonitrile

Similarity: 0.88

Chemical Structure| 33143-29-2

[ 33143-29-2 ]

2,2-Dimethyl-2H-chromene-6-carbonitrile

Similarity: 0.86

Chemical Structure| 330792-69-3

[ 330792-69-3 ]

2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile

Similarity: 0.86

Chemical Structure| 189439-24-5

[ 189439-24-5 ]

4-(Benzyloxy)-2-hydroxybenzonitrile

Similarity: 0.86

Chemical Structure| 6609-57-0

[ 6609-57-0 ]

2-Ethoxybenzonitrile

Similarity: 0.85

Related Parent Nucleus of
[ 79002-39-4 ]

Benzofurans

Chemical Structure| 50551-63-8

[ 50551-63-8 ]

6-Methoxybenzofuran

Similarity: 0.81

Chemical Structure| 13196-11-7

[ 13196-11-7 ]

Benzofuran-6-ol

Similarity: 0.81

Chemical Structure| 7168-85-6

[ 7168-85-6 ]

7-Methoxybenzofuran

Similarity: 0.78

Chemical Structure| 41717-32-2

[ 41717-32-2 ]

1-Benzofuran-2-carbonitrile

Similarity: 0.75

Chemical Structure| 10035-16-2

[ 10035-16-2 ]

Benzofuran-5-carbaldehyde

Similarity: 0.72